Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:371-376
Published online before print December 22, 2005, doi: 10.1161/01.STR.0000198843.72824.0a
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/2/371    most recent
01.STR.0000198843.72824.0av1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woo, D.
Right arrow Articles by Broderick, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woo, D.
Right arrow Articles by Broderick, J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Epidemiology

(Stroke. 2006;37:371.)
© 2006 American Heart Association, Inc.


Original Contributions

Association of Phosphodiesterase 4D With Ischemic Stroke

A Population-Based Case-Control Study

Daniel Woo, MD, MS; Ritesh Kaushal, MD; Brett Kissela, MD; Padmini Sekar, MS; Michael Wolujewicz, MS; Prodipto Pal, MD; Kathleen Alwell, RN; Mary Haverbusch, RN; Irene Ewing, RN; Rosie Miller, RN; Dawn Kleindorfer, MD; Matthew Flaherty, MD; Ranajit Chakraborty, PhD; Ranjan Deka, PhD Joseph Broderick, MD

From the Department of Neurology, University of Cincinnati College of Medicine, Ohio.

Correspondence to Daniel Woo, MD, Department of Neurology, University of Cincinnati College of Medicine, 231 Albert Sabin Way, ML 0525, Cincinnati, OH 45267-0525. E-mail Daniel.woo{at}uc.edu

Background and Purpose— The Phosphodiesterase 4D (PDE4D) gene was reported recently to be associated with ischemic stroke in an Icelandic population. The association was found predominately with large vessel and cardioembolic stroke. However, 2 recent reports were unable to confirm this association, although a trend toward association with cardioembolic stroke was reported. None of the reports included significant proportions of blacks. We tested for genotype and haplotype association of polymorphisms of the PDE4D gene with ischemic stroke in a population-based, biracial, case-control study.

Methods— A total of 357 cases of ischemic stroke and 482 stroke-free controls from the same community were examined. Single nucleotide polymorphisms (SNPs) were chosen based on significant associations reported previously. Linkage disequilibrium (LD), SNP, and haplotype association analysis was performed using PHASE 2.0 and Haploview 3.2.

Results— Although several univariate associations were identified, only 1 SNP (rs2910829) was found to be significantly associated with cardioembolic stroke among both whites and blacks. The rs152312 SNP was associated with cardioembolic stroke among whites after multiple comparison corrections. The same SNP was not associated with cardioembolic stroke among blacks. However, significant haplotype association was identified for both whites and blacks for all ischemic stroke, cardioembolic stroke, and stroke of unknown origin. Haplotype association was identified for small vessel stroke among whites.

Conclusions— PDE4D is a risk factor for ischemic stroke and, in particular, for cardioembolic stroke, among whites and blacks. Further study of this gene is warranted.


Key Words: epidemiology • genetics • stroke, ischemic




This article has been cited by other articles:


Home page
StrokeHome page
S. Bevan, M. Dichgans, A. Gschwendtner, G. Kuhlenbaumer, E.B. Ringelstein, and H. S. Markus
Variation in the PDE4D Gene and Ischemic Stroke Risk: A Systematic Review and Meta-analysis on 5200 Cases and 6600 Controls
Stroke, July 1, 2008; 39(7): 1966 - 1971.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Dichgans and R. A. Hegele
Update on the Genetics of Stroke and Cerebrovascular Disease 2006
Stroke, February 1, 2007; 38(2): 216 - 218.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J M Staton, M S Sayer, G J Hankey, J Attia, A Thakkinstian, Q Yi, V J Cole, R Baker, and J W Eikelboom
Association between phosphodiesterase 4D gene and ischaemic stroke.
J. Neurol. Neurosurg. Psychiatry, September 1, 2006; 77(9): 1067 - 1069.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. B. Worrall and J. C. Mychaleckyj
PDE4D and Stroke: A Real Advance or a Case of the Emperor's New Clothes?
Stroke, August 1, 2006; 37(8): 1955 - 1957.
[Full Text] [PDF]


Home page
StrokeHome page
V. H. Brophy, S. K. Ro, B. K. Rhees, L.-Y. Lui, J. M. Lee, N. Umblas, L. G. Bentley, J. Li, S. Cheng, W. S. Browner, et al.
Association of Phosphodiesterase 4D Polymorphisms With Ischemic Stroke in a US Population Stratified by Hypertension Status
Stroke, June 1, 2006; 37(6): 1385 - 1390.
[Abstract] [Full Text] [PDF]